Search Results - "Hobeika, A."

Refine Results
  1. 1

    Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS) by Zhao, Y., Qiao, G., Wang, X., Song, Y., Zhou, X., Jiang, N., Zhou, L., Huang, H., Zhao, J., Morse, M. A., Hobeika, A., Ren, J., Lyerly, H. K.

    Published in Clinical & translational oncology (01-06-2019)
    “…Background Advanced non-small cell lung cancer (NSCLC) has remained challenging to treat effectively. This study aimed to investigate the clinical effects and…”
    Get full text
    Journal Article
  2. 2

    Optimal evacuation planning using staging and routing by Bish, D R, Sherali, H D, Hobeika, A G

    “…Evacuation is an important disaster management tool. Evacuating a large region by automobile (the most commonly used mode) is a difficult task, especially as…”
    Get full text
    Journal Article
  3. 3

    Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA CD3-bispecific T-cell-engaging BiTE antibody by Osada, T, Hsu, D, Hammond, S, Hobeika, A, Devi, G, Clay, T M, Lyerly, H K, Morse, M A

    Published in British journal of cancer (05-01-2010)
    “…Background: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-γ treatment by Mosca, Paul J., Hobeika, Amy C., Clay, Timothy M., Nair, Smita K., Thomas, Elaine K., Morse, Michael A., Lyerly, H. Kim

    Published in Blood (15-11-2000)
    “…Dendritic cells (DCs) may arise from multiple lineages and progress through a series of intermediate stages until fully mature, at which time they are capable…”
    Get full text
    Journal Article
  6. 6

    Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function by Morse, M A, Hobeika, A, Serra, D, Aird, K, McKinney, M, Aldrich, A, Clay, T, Mourich, D, Lyerly, H K, Iversen, P L, Devi, G R

    Published in Cancer gene therapy (01-01-2012)
    “…CD4+CD25+regulatory T cells (T reg ) impair anti-tumor and anti-viral immunity. As there are higher T reg levels in cancer patients compared with healthy…”
    Get full text
    Journal Article
  7. 7

    Down-regulation of neu/HER-2 by interferon-γ in prostate cancer cells by KOMINSKY, S. L, HOBEIKA, A. C, LAKE, F. A, TORRES, B. A, JOHNSON, H. M

    Published in Cancer research (Chicago, Ill.) (15-07-2000)
    “…Interferons (IFNs) are known to possess potent antitumor properties. Previous studies have indicated that IFNs are capable of modulating the expression of…”
    Get full text
    Journal Article
  8. 8

    Evaluation Update of the Red Light Camera Program in Fairfax County, VA by Hobeika, A., Yaungyai, N.

    “…The Red Light Camera (RLC) program in Fairfax County, VA, had 13 cameras in operation in year 2003. This update study is conducted to evaluate the Fairfax…”
    Get full text
    Journal Article
  9. 9

    IFNα induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells by HOBEIKA, A. C, SUBRAMANIAM, P. S, JOHNSON, H. M

    Published in Oncogene (13-03-1997)
    “…Prostate cancer, like other types of cancer, is associated with the loss of cell cycle control, resulting in unregulated growth of cells. We report here on the…”
    Get full text
    Journal Article
  10. 10

    Liquid helium up to 160 bar by WERNER, F, BEAUME, G, HOBEIKA, A, NASCIMBENE, S, HERRMANN, C, CAUPIN, F, BALIBAR, S

    Published in Journal of low temperature physics (01-07-2004)
    “…We have used an acoustic technique to pressurize liquid helium 4 up to 163 - 20 bar. This is far above the liquid-solid equilibrium pressure Pm, which is 25.3…”
    Get full text
    Journal Article
  11. 11

    Assays for Monitoring Cellular Immune Responses to Active Immunotherapy of Cancer by CLAY, Timothy M, HOBEIKA, Amy C, MOSCA, Paul J, LYERLY, H. Kim, MORSE, Michael A

    Published in Clinical cancer research (01-05-2001)
    “…Numerous cancer immunotherapy strategies are currently being tested in clinical trials. Although clinical efficacy will be the final test of these approaches,…”
    Get full text
    Journal Article
  12. 12

    The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity by Soos, JM, Subramaniam, PS, Hobeika, AC, Schiffenbauer, J, Johnson, HM

    Published in The Journal of immunology (1950) (01-09-1995)
    “…Multiple sclerosis (MS) is an inflammatory demyelinating autoimmune disease if the central nervous system (CNS). Recently, the type I IFN, IFN-beta-1b was…”
    Get full text
    Journal Article
  13. 13

    En bloc resection of lacrimal sac tumors and simultaneous orbital reconstruction: surgical and functional outcomes by Alabiad, Chrisfouad R, Weed, Donald T, Walker, Thomas J, Vivero, Richard, Hobeika, Georges A, Hatoum, Georges F, Shriver, Erin M, Tse, David T

    “…To describe a surgical technique of en bloc resection of lacrimal sac tumors by the shared expertise of 2 specialists to achieve optimal tumor margin clearance…”
    Get full text
    Journal Article
  14. 14

    Comparison of traffic assignments in evacuation modeling by Hobeika, A.G., Changkyun Kim

    “…The Nuclear Regulatory Commission (NRC) requires that all electric utilities develop and update evacuation plans for the areas surrounding their nuclear power…”
    Get full text
    Journal Article
  15. 15

    Superantigens: the good, the bad, and the ugly by Torres, B A, Kominsky, S, Perrin, G Q, Hobeika, A C, Johnson, H M

    “…Increasing evidence suggests that superantigens play a role in immune-mediated diseases. Superantigens are potent activators of CD4+ T cells, causing rapid and…”
    Get more information
    Journal Article
  16. 16

    Time-Dependent, Label-Constrained Shortest Path Problems with Applications by Sherali, Hanif D, Hobeika, Antoine G, Kangwalklai, Sasikul

    Published in Transportation science (01-08-2003)
    “…In this paper, we consider a variant of shortest path problems where, in addition to congestion related time-dependent link travel times on a given…”
    Get full text
    Journal Article
  17. 17

    Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand by Mosca, Paul J, Hobeika, Amy C., Colling, Kirsten, Clay, Timothy M., Thomas, Elaine K., Caron, Dania, Lyerly, H. Kim, Morse, Michael A.

    Published in Journal of leukocyte biology (01-09-2002)
    “…The ligand for the receptor tyrosine kinase fms‐like tyrosine kinase 3(Flt3L) is a growth factor for hematopoietic progenitors and inducesexpansion of the two…”
    Get full text
    Journal Article
  18. 18

    IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis by Hobeika, A C, Etienne, W, Torres, B A, Johnson, H M, Subramaniam, P S

    Published in Journal of interferon & cytokine research (01-12-1999)
    “…Interferons (IFN) inhibit the growth of tumor cells by blocking the progression of their cell cycle. Recently, we showed that this cell cycle inhibition…”
    Get more information
    Journal Article
  19. 19

    Surrogate markers of response to cancer immunotherapy by Morse, M A, Clay, T M, Hobeika, A C, Mosca, P J, Lyerly, H K

    Published in Expert opinion on biological therapy (01-03-2001)
    “…Clinically effective cancer immunotherapy has been sought for more than 100 years and has been recently applied most successfully in strategies that passively…”
    Get more information
    Journal Article
  20. 20